Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 18 studies | 28% ± 15% | |
| endothelial cell | 17 studies | 25% ± 9% | |
| non-classical monocyte | 10 studies | 27% ± 13% | |
| fibroblast | 10 studies | 20% ± 5% | |
| astrocyte | 10 studies | 31% ± 13% | |
| microglial cell | 9 studies | 29% ± 9% | |
| monocyte | 9 studies | 27% ± 9% | |
| glutamatergic neuron | 8 studies | 42% ± 25% | |
| myeloid cell | 8 studies | 28% ± 6% | |
| ciliated cell | 8 studies | 27% ± 11% | |
| oligodendrocyte precursor cell | 7 studies | 27% ± 11% | |
| pericyte | 7 studies | 21% ± 3% | |
| epithelial cell | 7 studies | 37% ± 17% | |
| adipocyte | 7 studies | 22% ± 4% | |
| dendritic cell | 7 studies | 29% ± 12% | |
| type I pneumocyte | 7 studies | 20% ± 6% | |
| GABAergic neuron | 7 studies | 40% ± 19% | |
| oligodendrocyte | 7 studies | 26% ± 7% | |
| classical monocyte | 6 studies | 21% ± 8% | |
| interneuron | 6 studies | 37% ± 22% | |
| B cell | 5 studies | 19% ± 2% | |
| neuron | 5 studies | 36% ± 13% | |
| basal cell | 5 studies | 29% ± 13% | |
| mononuclear phagocyte | 5 studies | 22% ± 4% | |
| endothelial cell of lymphatic vessel | 5 studies | 25% ± 9% | |
| squamous epithelial cell | 4 studies | 32% ± 21% | |
| conventional dendritic cell | 4 studies | 26% ± 6% | |
| retina horizontal cell | 4 studies | 27% ± 7% | |
| retinal cone cell | 4 studies | 24% ± 4% | |
| natural killer cell | 4 studies | 17% ± 2% | |
| club cell | 4 studies | 24% ± 5% | |
| alveolar macrophage | 4 studies | 32% ± 12% | |
| goblet cell | 4 studies | 29% ± 19% | |
| GABAergic interneuron | 3 studies | 20% ± 3% | |
| granule cell | 3 studies | 20% ± 2% | |
| cardiac muscle cell | 3 studies | 19% ± 4% | |
| mesothelial cell | 3 studies | 22% ± 4% | |
| smooth muscle cell | 3 studies | 18% ± 4% | |
| Mueller cell | 3 studies | 18% ± 2% | |
| retinal rod cell | 3 studies | 15% ± 0% | |
| muscle cell | 3 studies | 24% ± 9% | |
| connective tissue cell | 3 studies | 18% ± 1% | |
| enteroendocrine cell | 3 studies | 23% ± 7% | |
| transit amplifying cell | 3 studies | 30% ± 19% | |
| mast cell | 3 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 4811.81 | 21 / 21 | 100% | 16.98 | 504 / 504 |
| esophagus | 100% | 3650.94 | 1445 / 1445 | 100% | 21.60 | 183 / 183 |
| intestine | 100% | 3656.05 | 966 / 966 | 100% | 15.16 | 527 / 527 |
| lung | 100% | 4368.37 | 578 / 578 | 100% | 17.90 | 1155 / 1155 |
| prostate | 100% | 3274.28 | 245 / 245 | 100% | 17.27 | 502 / 502 |
| stomach | 100% | 2923.07 | 359 / 359 | 100% | 15.77 | 286 / 286 |
| breast | 100% | 4023.29 | 459 / 459 | 100% | 28.34 | 1117 / 1118 |
| uterus | 100% | 4369.16 | 170 / 170 | 100% | 19.15 | 458 / 459 |
| brain | 100% | 2551.85 | 2636 / 2642 | 100% | 13.82 | 705 / 705 |
| ovary | 100% | 2830.77 | 180 / 180 | 100% | 18.07 | 429 / 430 |
| pancreas | 100% | 1774.00 | 327 / 328 | 100% | 16.28 | 178 / 178 |
| thymus | 100% | 2868.26 | 653 / 653 | 100% | 15.06 | 603 / 605 |
| adrenal gland | 100% | 3880.85 | 258 / 258 | 99% | 13.01 | 227 / 230 |
| kidney | 100% | 2451.15 | 89 / 89 | 99% | 11.83 | 889 / 901 |
| liver | 100% | 1815.08 | 226 / 226 | 98% | 9.25 | 398 / 406 |
| skin | 100% | 3484.22 | 1809 / 1809 | 97% | 12.87 | 456 / 472 |
| adipose | 100% | 3662.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 12.99 | 29 / 29 |
| muscle | 100% | 3406.87 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3365.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 20.01 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.96 | 1 / 1 |
| blood vessel | 100% | 2657.13 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 3020.23 | 916 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 2181.54 | 844 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 93% | 8.85 | 74 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
| GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
| GO_0045860 | Biological process | positive regulation of protein kinase activity |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0031625 | Molecular function | ubiquitin protein ligase binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CACUL1 |
| Protein name | CDK2-associated and cullin domain-containing protein 1 (Cdk-associated cullin 1) |
| Synonyms | CAC1 C10orf46 |
| Description | FUNCTION: Cell cycle associated protein capable of promoting cell proliferation through the activation of CDK2 at the G1/S phase transition. . |
| Accessions | ENST00000493518.5 [Q86Y37-2] Q86Y37 ENST00000369151.8 [Q86Y37-1] |